{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:00:52Z","timestamp":1780934452850,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clear cell renal cell carcinoma (ccRCC) has long been considered as a metabolic disease characterized by metabolic reprogramming due to the abnormal accumulation of lipid droplets in the cytoplasm. However, the prognostic value of metabolism-related genes in ccRCC remains unclear. In our study, we investigated the associations between metabolism-related gene profile and prognosis of ccRCC patients in the Cancer Genome Atlas (TCGA) database. Importantly, we first constructed a metabolism-related prognostic model based on ten genes (ALDH6A1, FBP1, HAO2, TYMP, PSAT1, IL4I1, P4HA3, HK3, CPT1B, and CYP26A1) using Lasso cox regression analysis. The Kaplan\u2013Meier analysis revealed that our model efficiently predicts prognosis in TCGA_KIRC Cohort and the clinical proteomic tumor analysis consortium (CPTAC_ccRCC) Cohort. Using time-dependent ROC analysis, we showed the model has optimal performance in predicting long-term survival. Besides, the multivariate Cox regression analysis demonstrated our model is an independent prognostic factor. The risk score calculated for each patient was significantly associated with various clinicopathological parameters. Notably, the gene set enrichment analysis indicated that fatty acid metabolism was enriched considerably in low-risk patients. In contrast, the high-risk patients were more associated with non-metabolic pathways. In summary, our study provides novel insight into metabolism-related genes\u2019 roles in ccRCC.<\/jats:p>","DOI":"10.1038\/s41598-020-67760-6","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T10:05:51Z","timestamp":1596189951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"67760_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334. https:\/\/doi.org\/10.3322\/caac.21551 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"67760_CR2","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.7150\/jca.31173","volume":"10","author":"X He","year":"2019","unstructured":"He, X. et al. Association of preoperative plasma D-dimmer and fibrinogen and renal cell carcinoma outcome. J. Cancer 10, 4096\u20134105. https:\/\/doi.org\/10.7150\/jca.31173 (2019).","journal-title":"J. Cancer"},{"key":"67760_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","volume":"14","author":"DY Heng","year":"2013","unstructured":"Heng, D. Y. et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 14, 141\u2013148. https:\/\/doi.org\/10.1016\/S1470-2045(12)70559-4 (2013).","journal-title":"Lancet Oncol."},{"key":"67760_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00345-018-2309-4","volume":"36","author":"T Klatte","year":"2018","unstructured":"Klatte, T., Rossi, S. H. & Stewart, G. D. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J. Urol. 36, 1943\u20131952. https:\/\/doi.org\/10.1007\/s00345-018-2309-4 (2018).","journal-title":"World J. Urol."},{"key":"67760_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.158571","author":"MAK Widjaja-Adhi","year":"2019","unstructured":"Widjaja-Adhi, M. A. K. & Golczak, M. The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates. Biochim. Biophys. Acta Mol. Cell Biol. Lipids https:\/\/doi.org\/10.1016\/j.bbalip.2019.158571 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"67760_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten, H. I., Aboud, O. A., Lara, P. N. Jr. & Weiss, R. H. Metabolic reprogramming in clear cell renal cell carcinoma. Nat. Rev. Nephrol. 13, 410\u2013419. https:\/\/doi.org\/10.1038\/nrneph.2017.59 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"67760_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli, G. et al. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma. Exp. Rev. Mol. Diagn. 19, 397\u2013407. https:\/\/doi.org\/10.1080\/14737159.2019.1607729 (2019).","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"67760_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan, W. M., Srinivasan, R. & Schmidt, L. S. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol. 7, 277\u2013285. https:\/\/doi.org\/10.1038\/nrurol.2010.47 (2010).","journal-title":"Nat. Rev. Urol."},{"key":"67760_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.eururo.2012.09.054","volume":"63","author":"S Sudarshan","year":"2013","unstructured":"Sudarshan, S. et al. Metabolism of kidney cancer: from the lab to clinical practice. Eur. Urol. 63, 244\u2013251. https:\/\/doi.org\/10.1016\/j.eururo.2012.09.054 (2013).","journal-title":"Eur. Urol."},{"key":"67760_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell, S. et al. Renal mass and localized renal cancer: AUA guideline. J. Urol. 198, 520\u2013529. https:\/\/doi.org\/10.1016\/j.juro.2017.04.100 (2017).","journal-title":"J. Urol."},{"key":"67760_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","volume":"5","author":"B Qiu","year":"2015","unstructured":"Qiu, B. et al. HIF2alpha-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5, 652\u2013667. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1507 (2015).","journal-title":"Cancer Discov."},{"key":"67760_CR12","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat. Commun."},{"key":"67760_CR13","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.18632\/aging.102407","volume":"11","author":"G Cheng","year":"2019","unstructured":"Cheng, G. et al. A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. Aging 11, 9597\u20139615. https:\/\/doi.org\/10.18632\/aging.102407 (2019).","journal-title":"Aging"},{"key":"67760_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12967-019-1824-4","volume":"17","author":"Q Song","year":"2019","unstructured":"Song, Q. et al. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J. Transl. Med. 17, 70. https:\/\/doi.org\/10.1186\/s12967-019-1824-4 (2019).","journal-title":"J. Transl. Med."},{"key":"67760_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18632\/aging.101738","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma. Aging 11, 160\u2013173. https:\/\/doi.org\/10.18632\/aging.101738 (2019).","journal-title":"Aging"},{"key":"67760_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semnephrol.2018.01.006","volume":"38","author":"RH Weiss","year":"2018","unstructured":"Weiss, R. H. Metabolomics and metabolic reprogramming in kidney cancer. Semin. Nephrol. 38, 175\u2013182. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.01.006 (2018).","journal-title":"Semin. Nephrol."},{"key":"67760_CR17","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.18632\/aging.102746","volume":"12","author":"X Hua","year":"2020","unstructured":"Hua, X., Chen, J., Su, Y. & Liang, C. Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma. Aging 12, 2302\u20132332. https:\/\/doi.org\/10.18632\/aging.102746 (2020).","journal-title":"Aging"},{"key":"67760_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature13557","volume":"513","author":"B Li","year":"2014","unstructured":"Li, B. et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513, 251\u2013255. https:\/\/doi.org\/10.1038\/nature13557 (2014).","journal-title":"Nature"},{"key":"67760_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","volume":"36","author":"S Gao","year":"2017","unstructured":"Gao, S. et al. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3beta\/beta-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer. J. Exp. Clin. Cancer Res. CR 36, 179. https:\/\/doi.org\/10.1186\/s13046-017-0648-4 (2017).","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"67760_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1598752","author":"J Jiang","year":"2019","unstructured":"Jiang, J. et al. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma. Autophagy https:\/\/doi.org\/10.1080\/15548627.2019.1598752 (2019).","journal-title":"Autophagy"},{"key":"67760_CR21","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1038\/s41467-019-11452-x","volume":"10","author":"PA Stewart","year":"2019","unstructured":"Stewart, P. A. et al. Proteogenomic landscape of squamous cell lung cancer. Nat. Commun. 10, 3578. https:\/\/doi.org\/10.1038\/s41467-019-11452-x (2019).","journal-title":"Nat. Commun."},{"key":"67760_CR22","doi-asserted-by":"publisher","first-page":"12590","DOI":"10.1074\/jbc.275.17.12590","volume":"275","author":"JM Jones","year":"2000","unstructured":"Jones, J. M., Morrell, J. C. & Gould, S. J. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J. Biol. Chem. 275, 12590\u201312597. https:\/\/doi.org\/10.1074\/jbc.275.17.12590 (2000).","journal-title":"J. Biol. Chem."},{"key":"67760_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jhep.2015.11.029","volume":"64","author":"S Mattu","year":"2016","unstructured":"Mattu, S. et al. The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival. J. Hepatol. 64, 891\u2013898. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.029 (2016).","journal-title":"J. Hepatol."},{"key":"67760_CR24","doi-asserted-by":"publisher","first-page":"23005","DOI":"10.1002\/jcp.28861","volume":"234","author":"W Xiao","year":"2019","unstructured":"Xiao, W., Wang, X., Wang, T., Chen, B. & Xing, J. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process. J. Cell. Physiol. 234, 23005\u201323016. https:\/\/doi.org\/10.1002\/jcp.28861 (2019).","journal-title":"J. Cell. Physiol."},{"key":"67760_CR25","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.21873\/anticanres.13021","volume":"38","author":"SY Cho","year":"2018","unstructured":"Cho, S. Y. et al. HSP27, ALDH6A1 and prohibitin act as a trio-biomarker to predict survival in late metastatic prostate cancer. Anticancer Res. 38, 6551\u20136560. https:\/\/doi.org\/10.21873\/anticanres.13021 (2018).","journal-title":"Anticancer Res."},{"key":"67760_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcm.2017.10.003","volume":"28","author":"W Li","year":"2018","unstructured":"Li, W. & Yue, H. Thymidine phosphorylase: a potential new target for treating cardiovascular disease. Trends Cardiovasc. Med. 28, 157\u2013171. https:\/\/doi.org\/10.1016\/j.tcm.2017.10.003 (2018).","journal-title":"Trends Cardiovasc. Med."},{"key":"67760_CR27","first-page":"61","volume":"56","author":"E Miszczak-Zaborska","year":"2010","unstructured":"Miszczak-Zaborska, E., Smolarek, M. & Bartkowiak, J. Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors. Postepy Biochem. 56, 61\u201366 (2010).","journal-title":"Postepy Biochem."},{"key":"67760_CR28","doi-asserted-by":"publisher","first-page":"153303381879648","DOI":"10.1177\/1533033818796485","volume":"17","author":"H Song","year":"2018","unstructured":"Song, H. et al. P4HA3 is epigenetically activated by slug in gastric cancer and its deregulation is associated with enhanced metastasis and poor survival. Technol. Cancer Res. Treat. 17, 1533033818796485. https:\/\/doi.org\/10.1177\/1533033818796485 (2018).","journal-title":"Technol. Cancer Res. Treat."},{"key":"67760_CR29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/eji.201041119","volume":"41","author":"F Lasoudris","year":"2011","unstructured":"Lasoudris, F. et al. IL4I1: an inhibitor of the CD8(+) antitumor T-cell response in vivo. Eur. J. Immunol. 41, 1629\u20131638. https:\/\/doi.org\/10.1002\/eji.201041119 (2011).","journal-title":"Eur. J. Immunol."},{"key":"67760_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12864-018-4477-4","volume":"19","author":"EA Pudova","year":"2018","unstructured":"Pudova, E. A. et al. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genom. 19, 113. https:\/\/doi.org\/10.1186\/s12864-018-4477-4 (2018).","journal-title":"BMC Genom."},{"key":"67760_CR31","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1158\/1078-0432.CCR-18-1515","volume":"25","author":"V Vantaku","year":"2019","unstructured":"Vantaku, V. et al. Multi-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in bladder cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 25, 3689\u20133701. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1515 (2019).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"67760_CR32","first-page":"1017","volume":"7","author":"I Klaassen","year":"2001","unstructured":"Klaassen, I., Brakenhoff, R. H., Smeets, S. J., Snow, G. B. & Braakhuis, B. J. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 7, 1017\u20131025 (2001).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"67760_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/1756-0500-7-697","volume":"7","author":"M Osanai","year":"2014","unstructured":"Osanai, M. & Lee, G. H. Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer. BMC Res. Notes 7, 697. https:\/\/doi.org\/10.1186\/1756-0500-7-697 (2014).","journal-title":"BMC Res. Notes"},{"key":"67760_CR34","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucl. Acids Res."},{"key":"67760_CR35","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.7314\/apjcp.2015.16.15.6773","volume":"16","author":"HR Shahraki","year":"2015","unstructured":"Shahraki, H. R., Salehi, A. & Zare, N. Survival prognostic factors of male breast cancer in Southern Iran: a LASSO-Cox regression approach. Asian Pac. J. Cancer Prev. 16, 6773\u20136777. https:\/\/doi.org\/10.7314\/apjcp.2015.16.15.6773 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"67760_CR36","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.12659\/MSM.917399","volume":"25","author":"Q Pan","year":"2019","unstructured":"Pan, Q., Wang, L., Zhang, H., Liang, C. & Li, B. Identification of a 5-gene signature predicting progression and prognosis of clear cell renal cell carcinoma. Med. Sci. Monit. 25, 4401\u20134413. https:\/\/doi.org\/10.12659\/MSM.917399 (2019).","journal-title":"Med. Sci. Monit."},{"key":"67760_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty, P. J. & Zheng, Y. Survival model predictive accuracy and ROC curves. Biometrics 61, 92\u2013105. https:\/\/doi.org\/10.1111\/j.0006-341X.2005.030814.x (2005).","journal-title":"Biometrics"},{"key":"67760_CR38","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.7150\/jca.35785","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms. J. Cancer 10, 5944\u20135954. https:\/\/doi.org\/10.7150\/jca.35785 (2019).","journal-title":"J. Cancer"},{"key":"67760_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"67760_CR40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3892\/ijo.2019.4849","volume":"55","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma. Int. J. Oncol. 55, 645\u2013656. https:\/\/doi.org\/10.3892\/ijo.2019.4849 (2019).","journal-title":"Int. J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67760-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:23:47Z","timestamp":1670340227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67760-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67760"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67760-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12949"}}